Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
Titel:
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
Auteur:
Huober, J. Fasching, P.A. Barsoum, M. Petruzelka, L. Wallwiener, D. Thomssen, C. Reimer, T. Paepke, S. Azim, H.A. Ragosch, V. Kubista, E. Baumgärtner, A.K. Beckmann, M.W. May, C. Nimmrich, I. Harbeck, N.